Skip to content
value.today

Bioscale Inc.

Total raised
$45 M
5 rounds on record
Latest round
$19 M
Jun 2013
First round on record
May 2010
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Bioscale Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2013$19 MNo. 5$10 to $50 million

Bioscale Inc.: Raise no. 5, Jun 2013

Investors in this round

69 investors had bought by the notice of Jul 8, 2013: 69 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$19 M of $38 M offered; $20 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brett Masters · Executive Officer
  • Chip Leveille · Executive Officer
  • Dr. Martin Latterich · Executive Officer
  • Mark Lundstrom · Executive Officer, Director
  • Bard Geesaman · Director
  • Edward Crawley · Director
  • Isaac Cheng · Director
  • Somu Subramaniam · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Lundstrom, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 8, 2013. Read the notice at the SEC.

equitySEC
Jan 2013$1 MNo. 4Under $2 million

Bioscale Inc.: Raise no. 4, Jan 2013

Investors in this round

25 investors had bought by the notice of Mar 11, 2013: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $5 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brett Masters · Executive Officer
  • Chip Leveille · Executive Officer
  • Dr. Martin Latterich · Executive Officer
  • Mark Lundstrom · Executive Officer, Director
  • Bard Geesaman · Director
  • Bill Doyle · Director
  • Edward Crawley · Director
  • Isaac Cheng · Director
  • Riccardo Pigliucci · Director
  • Somu Subramaniam · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes Notes and Warrants that may be sold and issued at additional closings”

Signed by Mark Lundstrom, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 11, 2013. Read the notice at the SEC.

debt, optionsSEC
Oct 2012$4 MNo. 3$2 to $10 million

Bioscale Inc.: Raise no. 3, Oct 2012

Investors in this round

62 investors had bought by the notice of Feb 21, 2013: 62 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $11 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brett E. Masters · Executive Officer
  • Chip E. Leveille · Executive Officer
  • Dr. Martin J. Latterich · Executive Officer
  • Mark E. Lundstrom · Executive Officer, Director
  • Bard J. Geesaman · Director
  • Edward F. Crawley · Director
  • Isaac S. Cheng · Director
  • Riccardo J. Pigliucci · Director
  • Somu J. Subramaniam · Director
  • William F. Doyle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Offering amount includes the issuance of Warrants to purchase preferred stock.”

Signed by Mark Lundstrom, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 21, 2013. Read the notice at the SEC.

debt, optionsSEC
Feb 2012$5 MNo. 2$2 to $10 million

Bioscale Inc.: Raise no. 2, Feb 2012

Investors in this round

37 investors had bought by the notice of Mar 6, 2012: 37 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $11 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brett Masters · Executive Officer
  • Chip Leveille · Executive Officer
  • Mark Lundstrom · Executive Officer, Director
  • Bard Geesaman · Director
  • Bill Doyle · Director
  • Edward Crawley · Director
  • Isaac Cheng · Director
  • Riccardo Pigliucci · Director
  • Somu Subramaniam · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Lundstrom, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 6, 2012. Read the notice at the SEC.

debt, optionsSEC
May 2010$16 MNo. 1$10 to $50 million

Bioscale Inc.: Raise no. 1, May 2010

Investors in this round

42 investors had bought by the notice of Jun 11, 2010: 42 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $25 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mark Lundstrom · Executive Officer, Director
  • Bard Geesaman · Director
  • Edward Crawley · Director
  • Isaac Cheng · Director
  • Paul Billings · Director
  • Somu Subramanian · Director
  • William Doyle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Lundstrom, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 11, 2010. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Bioscale Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2013).

    SEC Form D · Jul 2013

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2013

That is all the official record says: Bioscale Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Bioscale Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 69 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Bioscale Inc.
NameRoleNamed in
Brett MastersExecutive officerJul 2013
Chip LeveilleExecutive officerJul 2013
Dr. Martin LatterichExecutive officerJul 2013
Mark LundstromExecutive officerJul 2013
Brett E. MastersExecutive officerFeb 2013
Chip E. LeveilleExecutive officerFeb 2013
Dr. Martin J. LatterichExecutive officerFeb 2013
Mark E. LundstromExecutive officerFeb 2013
Bard GeesamanDirectorJul 2013
Edward CrawleyDirectorJul 2013
Isaac ChengDirectorJul 2013
Mark LundstromDirectorJul 2013
Somu SubramaniamDirectorJul 2013
Bill DoyleDirectorMar 2013
Riccardo PigliucciDirectorMar 2013
Bard J. GeesamanDirectorFeb 2013
Edward F. CrawleyDirectorFeb 2013
Isaac S. ChengDirectorFeb 2013
Mark E. LundstromDirectorFeb 2013
Riccardo J. PigliucciDirectorFeb 2013
Somu J. SubramaniamDirectorFeb 2013
William F. DoyleDirectorFeb 2013
Paul BillingsDirectorJun 2010
Somu SubramanianDirectorJun 2010
William DoyleDirectorJun 2010